UNH - UnitedHealth Group Incorporated

NYSE - NYSE Delayed Price. Currency in USD
271.13
+5.80 (+2.19%)
At close: 4:01PM EST
Stock chart is not supported by your current browser
Previous Close265.33
Open267.79
Bid0.00 x 1200
Ask271.50 x 3000
Day's Range266.62 - 271.13
52 Week Range212.50 - 287.94
Volume3,673,690
Avg. Volume4,026,219
Market Cap260.16B
Beta (3Y Monthly)1.06
PE Ratio (TTM)22.24
EPS (TTM)12.19
Earnings DateApr 15, 2019 - Apr 22, 2019
Forward Dividend & Yield3.60 (1.36%)
Ex-Dividend Date2018-11-30
1y Target Est306.39
Trade prices are not sourced from all markets
  • These are the most beloved stocks in the Dow
    CNBC Videos3 days ago

    These are the most beloved stocks in the Dow

    Wall Street's Dow darlings. With CNBC's Melissa Lee and the Fast Money traders, Tim Seymour, Karen Finerman, Dan Nathan and Guy Adami.

  • Buy UnitedHealth? Sell General Dynamics for Boeing? The traders take your questions
    CNBC Videos5 days ago

    Buy UnitedHealth? Sell General Dynamics for Boeing? The traders take your questions

    The "Halftime Report" traders take viewer questions on UnitedHealth, General Dynamics, Boeing, and Texas Instruments.

  • Why Is UnitedHealth (UNH) Up 0.9% Since Last Earnings Report?
    Zacks3 days ago

    Why Is UnitedHealth (UNH) Up 0.9% Since Last Earnings Report?

    UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • UnitedHealthcare Vision Plans Again Rank Highest in Customer Satisfaction in J.D. Power Report
    Business Wire3 days ago

    UnitedHealthcare Vision Plans Again Rank Highest in Customer Satisfaction in J.D. Power Report

    UnitedHealthcare Vision plans tied for highest in customer satisfaction among the nation’s vision carriers, according to the J.D. Power 2018 Vision Plan Satisfaction ReportSM. This

  • Here's Why Investing in Molina Healthcare (MOH) Makes Sense
    Zacks3 days ago

    Here's Why Investing in Molina Healthcare (MOH) Makes Sense

    Banking on higher net income and a solid 2018 performance, Molina Healthcare (MOH) holds potential as a promising investment option.

  • Stock Market News For Feb 12, 2019
    Zacks5 days ago

    Stock Market News For Feb 12, 2019

    Markets closed mostly higher on Monday as fresh rounds of trade talks between the United States and China began.

  • InvestorPlace4 days ago

    UnitedHealth Stock Is a Buy, but Keep an Eye on the External Risks

    The case for insurer UnitedHealth Group (NYSE:UNH) seems almost too easy to make. UNH stock already has been one of the best performers in the market, rising 270% over the past five years. Earnings are expected to grow about 13% in 2019. Yet UnitedHealth stock trades at a seemingly attractive 18x multiple to this year's EPS guidance.With a 10% pullback from early December highs, a cheaper price seems to set up an attractive opportunity. UNH's recent performance and huge earnings growth speak well of management. The company's Optum unit is cutting-edge, and growing revenue while expanding margins. With $226 billion in revenue, meanwhile, UnitedHealth has the scale to serve customers and the size to pressure suppliers.All else equal, I'd expect UnitedHealth stock to keep climbing. Indeed, I recommended UNH a year ago, and even ~15% higher, I'm still bullish. But there are risks here, highlighted by near-term trading in UnitedHealth stock. And investors need to understand those risks before proceeding.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 9 U.S. Stocks That Are Coming to Life Again The Case for UnitedHealth StockThis simply seems like a good business. Growth has been phenomenal. The midpoint of 2019 EPS guidance of $14.40-$14.70 suggests a 155% increase from 2014 levels.Obviously, a lower tax rate and acquisitions have provided some outside help. But this is a company operating well, with revenue and margins both rising.UNH has a diversified portfolio, too. It has its hands in seemingly every market, with the insurer serving employers, individuals, Medicare, and state and local governments. The Global segment, built through targeted M&A, is now a $10 billion-plus revenue business.And Optum is at the forefront of changes in the industry. 2018 revenue rose double-digits, and operating margins continued to expand. Other PBMs (pharmacy benefit managers) are struggling. Rite Aid (NYSE:RAD) unit EnvisionRx has disappointed. Express Scripts managed to sell itself to Cigna (NYSE:CI), but at only a modest premium to 2015 highs. In that context, Optum's performance is even more impressive.This seems simply like a very attractive business. It's the largest health insurer in the world. Optum remains a roaring success. And yet UNH stock isn't that expensive, trading at less than 18x the midpoint of FY19 EPS guidance.Double-digit annual EPS growth, a 1.4% dividend and potentially a higher multiple over time mean UnitedHealth could return 10%+ annually for years to come. The Two Key Risks to UNH StockThere are two key risks, however. The first is that competitors are trying to gain scale themselves and expand their reach. Cigna bought out Express Scripts. CVS (NYSE:CVS) acquired Aetna. Rivals are coming after UnitedHealth's market lead.To be fair, larger mergers haven't played out. Cigna and Anthem (NYSE:ANTM) planned to merge back in 2017, but called it off. Aetna and Humana (NYSE:HUM) did the same. But competitors are trying to copy at least some of UnitedHealth's strategy, and their success could make them more formidable foes.The bigger risk is on the political front. UNH stock has struggled in recent sessions after the Trump Administration announced a plan to end drug rebates (which benefit PBMs like Optum). An apparently ham-handed response from Optum, which asked for 21 month's notice of any changes from drug manufacturers, brought some unwanted publicity, and framed Optum as potentially part of the problem - not the solution.From a long term standpoint, UnitedHealth almost certainly can adapt to any changes. But with net margins only just above 5%, even modest pressure on pricing, reimbursements, or other areas of the business can have a big impact on overall profits. And in the short-term, noise around regulatory changes could impact UnitedHealth stock, as appears to have been the case of late. A Matter of TrustAt these levels, at least some of the risks are priced in. And I'd be loath to put too much faith in the federal government, in particular, doing anything to notably change the healthcare model in the U.S.But that could change. A scenario where a Democratic candidate wins the Presidency in 2020 and is backed by a Democratic Congress is far from impossible. Should such a scenario seem plausible next year, UNH stock could start pricing in that risk.Right now, 18x earnings might seem cheap but it's not hard to picture UNH trading at 13-14x (or even worse) if investors believe regulators are coming for the company's margins.The changing political landscape and UnitedHealth's exposure to that landscape, mean this isn't a set-it-and-forget-it stock. Investors need to understand the risks and be willing to be nimble if political risk, in particular, starts to creep up.In the meantime, however, the pullback in UNH stock makes an attractive business available at an enviable price. And that's enough to make UNH a buy - at least for now.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 7 Best Video Game Stocks to Power Up Your Portfolio! * 7 Forever Stocks to Buy for Long-Term Gains * 5 Self-Driving Car Stocks to Buy Compare Brokers The post UnitedHealth Stock Is a Buy, but Keep an Eye on the External Risks appeared first on InvestorPlace.

  • Ex-Mayo Clinic CEO Dr. John Noseworthy joining UnitedHealth's board of directors
    American City Business Journals4 days ago

    Ex-Mayo Clinic CEO Dr. John Noseworthy joining UnitedHealth's board of directors

    Dr. John Noseworthy, who just stepped down as CEO of Mayo Clinic, is keeping a presence in the health care field as he joins the board of directors of the Minnetonka-based health care giant.

  • Business Wire4 days ago

    John H. Noseworthy, M.D., Joins UnitedHealth Group Board of Directors

    The board of directors of UnitedHealth Group (UNH) announced John H. Noseworthy, M.D., has joined the board. Stephen J. Hemsley, executive chairman of the board of directors of UnitedHealth Group, said: “John Noseworthy has served health care as an exceptionally talented and compassionate physician, a leading neurological researcher and educator, and as CEO of one of the most widely recognized and admired health systems in the United States and worldwide, Mayo Clinic.

  • GuruFocus.com5 days ago

    UnitedHealth Group Inc (UNH) Files 10-K for the Fiscal Year Ended on December 31, 2018

    UnitedHealth Group Inc is a diversified health care company in the United States. The dividend yield of UnitedHealth Group Inc stocks is 1.31%. UnitedHealth Group Inc had annual average EBITDA growth of 13.70% over the past ten years.

  • MarketWatch6 days ago

    Dow turns negative in morning trade as declines in Disney, UnitedHealth stocks weigh

    The Dow Jones Industrial Average pivoted lower Monday monrng, after opening with modest gains, as shares of Walt Disney Co. and UnitedHealth Group Inc. pressured the blue-chip gauge lower. The Dow most recently was down by about 28 points, or 0.1%, at 25,075, with shares of UnitedHealth and Disney contributing about 30 points, or nearly all of the gauge's declines. Meanwhile, the other major indexes were trimming their earlier advance, with the S&P 500 index trading flat at 2,708 and the Nasdaq Composite Index holding on to a gain of about 0.2% at 7,308. All three major U.S. stock benchmarks had opened with firmer gains on Monday.

  • Top Ranked Value Stocks to Buy for February 11th
    Zacks6 days ago

    Top Ranked Value Stocks to Buy for February 11th

    Top Ranked Value Stocks to Buy for February 11th

  • Dow Jones Today: UnitedHealth, Intel Lead Blue Chips Lower; Merck Sets Up
    Investor's Business Daily9 days ago

    Dow Jones Today: UnitedHealth, Intel Lead Blue Chips Lower; Merck Sets Up

    Sellers were back in the stock market Friday after the Nasdaq composite and S&P 500 suffered distribution days Thursday. In the Dow Jones today, Merck rose.

  • The World's Top 10 Health Care Companies (UNH, MDT)
    Investopedia9 days ago

    The World's Top 10 Health Care Companies (UNH, MDT)

    Discover the world's top 10 health care companies according to market capitalization, including a brief summary of each.

  • Investing.com9 days ago

    UnitedHealth Falls 3%

    Investing.com - UnitedHealth (NYSE:UNH) fell by 3.09% to trade at $260.69 by 14:52 (19:52 GMT) on Friday on the NYSE exchange.

  • Markit9 days ago

    See what the IHS Markit Score report has to say about UnitedHealth Group Inc.

    UnitedHealth Group Inc NYSE:UNHView full report here! Summary * Perception of the company's creditworthiness is positive * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for UNH with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting UNH. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding UNH totaled $15.25 billion. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swap | PositiveThe current level displays a positive indicator. UNH credit default swap spreads are near the lowest level of the last one year and indicate improvement in the market's perception of the company's credit worthiness.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • UnitedHealthcare Confronts the Opioid Epidemic by Introducing Oral Health Programs and Policies
    Business Wire10 days ago

    UnitedHealthcare Confronts the Opioid Epidemic by Introducing Oral Health Programs and Policies

    MINNETONKA, Minn.-- -- Approach includes pharmacy policy and informational campaigns for the public, dental health professionals and UnitedHealthcare dental plan participants Oral health professionals write 12 percent of all opioid prescriptions, including 45 percent of opioid prescriptions for adolescents 1 – an age group especially vulnerable to addiction Efforts part of UnitedHealthcare’s comprehensive ...

  • Top Ranked Value Stocks to Buy for February 7th
    Zacks10 days ago

    Top Ranked Value Stocks to Buy for February 7th

    Top Ranked Value Stocks to Buy for February 7th

  • UnitedHealth Group Incorporated (NYSE:UNH): The Best Of Both Worlds
    Simply Wall St.11 days ago

    UnitedHealth Group Incorporated (NYSE:UNH): The Best Of Both Worlds

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! UnitedHealth Group Incorporated (NYSE:UNH) is a stock Read More...

  • David Carlson Buys UnitedHealth, Mastercard
    GuruFocus.com12 days ago

    David Carlson Buys UnitedHealth, Mastercard

    David Carlson (Trades, Portfolio), manager of the Elfun Trusts, bought shares of the following stocks in the fourth quarter. Warning! GuruFocus has detected 6 Warning Sign with UNH. The guru bought 100,000 shares of UnitedHealth Group Inc. (UNH), expanding the equity portfolio 1.05%.

  • IBD 50 Stocks To Watch: Blue Chip UnitedHealth Shapes Bullish Base
    Investor's Business Daily12 days ago

    IBD 50 Stocks To Watch: Blue Chip UnitedHealth Shapes Bullish Base

    Among the IBD 50 stocks to watch, Dow Jones stock UnitedHealth is outperforming the broad market, as it nears a new buy point.

  • BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue?
    Zacks12 days ago

    BioTelemetry (BEAT) Hits 52-Week High, Can the Run Continue?

    BioTelemetry (BEAT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

  • UnitedHealth, MercadoLibre, Alphabet and Gilead highlighted as Zacks Bull and Bear of the Day
    Zacks12 days ago

    UnitedHealth, MercadoLibre, Alphabet and Gilead highlighted as Zacks Bull and Bear of the Day

    UnitedHealth, MercadoLibre, Alphabet and Gilead highlighted as Zacks Bull and Bear of the Day

  • The Zacks Analyst Blog Highlights: UnitedHealth, Banco Bradesco, Itau, Banco Santander and Rio
    Zacks12 days ago

    The Zacks Analyst Blog Highlights: UnitedHealth, Banco Bradesco, Itau, Banco Santander and Rio

    The Zacks Analyst Blog Highlights: UnitedHealth, Banco Bradesco, Itau, Banco Santander and Rio

  • The Zacks Analyst Blog Highlights: Microsoft, Facebook, UnitedHealth, Mastercard and ExxonMobil
    Zacks12 days ago

    The Zacks Analyst Blog Highlights: Microsoft, Facebook, UnitedHealth, Mastercard and ExxonMobil

    The Zacks Analyst Blog Highlights: Microsoft, Facebook, UnitedHealth, Mastercard and ExxonMobil